AMERANT BAN ($AMTB) posted quarterly earnings results on Wednesday, April 23rd. The company reported earnings of $0.24 per share, missing estimates of $0.40 by $0.16. The company also reported revenue of $105,430,000, beating estimates of $103,869,660 by $1,560,340.
You can see Quiver Quantitative's $AMTB stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AMERANT BAN Insider Trading Activity
AMERANT BAN insiders have traded $AMTB stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $AMTB stock by insiders over the last 6 months:
- HOWARD A. LEVINE (See remarks) sold 3,628 shares for an estimated $83,580
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AMERANT BAN Hedge Fund Activity
We have seen 73 institutional investors add shares of AMERANT BAN stock to their portfolio, and 39 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- GOLDMAN SACHS GROUP INC added 443,445 shares (+72.9%) to their portfolio in Q4 2024, for an estimated $9,937,602
- BLACKROCK, INC. added 395,687 shares (+16.0%) to their portfolio in Q4 2024, for an estimated $8,867,345
- STATE STREET CORP added 272,456 shares (+33.7%) to their portfolio in Q4 2024, for an estimated $6,105,738
- KENNEDY CAPITAL MANAGEMENT LLC added 268,486 shares (+40.2%) to their portfolio in Q4 2024, for an estimated $6,016,771
- BOOTHBAY FUND MANAGEMENT, LLC removed 260,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $5,826,600
- VERITION FUND MANAGEMENT LLC added 247,145 shares (+71.5%) to their portfolio in Q4 2024, for an estimated $5,538,519
- ALLIANCEBERNSTEIN L.P. removed 246,690 shares (-81.6%) from their portfolio in Q4 2024, for an estimated $5,528,322
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
